Collectively, these findings suggest that high levels of KDM6B initiate a neuronal differentiation program in neuroblastoma cells by conferring an epigenetically active chromatin state to neuronal genes for transcriptional activation. The gene discussed is KDM6B; the disease is neuroblastoma.